2016/11/07 6:00 PM

Neovacs enrolls the first U.S. Patient in Phase IIb study of IFNa Kinoid for treatment of Systemic Lupus Erythematosus (SLE)

Information only available in PDF version.


This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: yJudaZSaapycnmlslJiXbmhsbpuWxJPJmGnJk2hxaZ2ab2lgxmhlZ52eZm9onWho
- Check this key: https://www.security-master-key.com.